H
Harald Arnesen
Researcher at Oslo University Hospital
Publications - 349
Citations - 15818
Harald Arnesen is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Myocardial infarction & Coronary artery disease. The author has an hindex of 61, co-authored 329 publications receiving 14829 citations. Previous affiliations of Harald Arnesen include University of Oslo.
Papers
More filters
Journal ArticleDOI
Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.
Ketil Lunde,Svein Solheim,Svend Aakhus,Harald Arnesen,Michael Abdelnoor,Torstein Egeland,Knut Endresen,Arnfinn Ilebekk,Arild Mangschau,J G Fjeld,Hans-Jørgen Smith,Eli Taraldsrud,Haakon K. Grøgaard,Reidar Bjørnerheim,Magne Brekke,Carl Müller,Einar Hopp,Asgrimur Ragnarsson,Jan E. Brinchmann,Kolbjørn Forfang +19 more
TL;DR: A randomized, controlled trial found no effects of intracoronary injection of autologous mononuclear BMC on global left ventricular function.
Journal ArticleDOI
Warfarin, aspirin, or both after myocardial infarction
TL;DR: Warfarin, in combination with aspirin or given alone, was superior to aspirin alone in reducing the incidence of composite events after an acute myocardial infarction but was associated with a higher risk of bleeding.
Journal ArticleDOI
The effect of warfarin on mortality and reinfarction after myocardial infarction.
TL;DR: Long-term therapy with warfarin has an important beneficial effect after myocardial infarction and can be recommended in the treatment of patients who survive the acute phase.
Journal ArticleDOI
Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease.
Raffaele De Caterina,Steen Husted,Lars Wallentin,Felicita Andreotti,Harald Arnesen,Fedor Bachmann,Colin Baigent,Kurt Huber,Jørgen Jespersen,Steen Dalby Kristensen,Gregory Y.H. Lip,João Morais,Lars Hvilsted Rasmussen,Agneta Siegbahn,Freek W.A. Verheugt,Jeffrey I. Weitz +15 more
TL;DR: The mechanisms of action, pharmacological properties and side effects of parenteral anticoagulants used in the management of coronary heart disease treated with or without percutaneous coronary interventions, cardioversion for atrial fibrillation, and prosthetic heart valves and valve repair are reviewed.
Journal ArticleDOI
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology.
Phillippe Gabriel Steg,Kurt Huber,Felicita Andreotti,Harald Arnesen,Dan Atar,Lina Badimon,J.-P Bassand,R. De Caterina,J. A. Eikelboom,Dietrich C. Gulba,Martial Hamon,Gérard Helft,Keith A.A. Fox,Steen Dalby Kristensen,Sunil V. Rao,F. W. A. Verheugt,Petr Widimsky,Uwe Zeymer,Jean-Philippe Collet +18 more
TL;DR: Current knowledge regarding the epidemiology of bleeding in ACS and percutaneous coronary intervention is summarized, including measurement and definitions of bleeding, with emphasis on the recent consensus Bleeding Academic Research Consortium (BARC) definitions.